[Two years' clinical experience with norethisterone enanthate as a prolonged-action injectable contraceptive].
Larranaga
A
A
Kesseru
E
E
D000568:Amenorrhea; D001695:Biology; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D004194:Disease; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D006470:Hemorrhage; D007267:Injections; D007774:Lactation; D008599:Menstruation Disturbances; D008796:Metrorrhagia; D009640:Norethindrone; D010827:Physiology; D011247:Pregnancy; D012106:Research; D012816:Signs and Symptoms
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D009640:Norethindrone
Amenorrhea; Biology; Bleeding; Clinical Research; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Effectiveness; Contraceptive Methods; Diseases; Family Planning; Injectables; Lactation; Maternal Physiology; Menstruation Disorders; Metrorrhagia; Norethindrone; Norethindrone Enanthate; Physiology; Research Methodology; Reversibility; Signs And Symptoms; Use-effectiveness